Shinji Makino, D.V.M., Ph.D.

Shinji Makino, D.V.M., Ph.D.

Edgar and Mary Frances Monteith Distinguished Professorship in Viral Genetics;
Professor, Department of Microbiology and Immunology;
Special Member, Experimental Pathology Graduate Program

University of Texas Medical Branch
301 University Blvd,
Galveston, TX 77555-1019

Office: (409) 772-2323
Fax: (409) 772-5065
shmakino@utmb.edu

« Back

Shinji Makino, D.V.M., Ph.D.

Professional Education

Degree Institution Field of Study Graduation Year
D.V.M.

Department of Veterinary Medicine, Faculty of Agriculture, Iwate University, Morioka, Japan

Veterinary Medicine 1979
Ph.D. Department of Animal Pathology, Institute of Medical Science, University of Tokyo, Tokyo, Japan Virology 1984
Fellowship Japan National Predoctoral Fellowship   1979-1984
Fellowship Invitation Fellowhip Program for Research, Japan Society for the Promotion of Science   2002

Honors

1990 URI Summer Research Award, University of Texas

Professional Affiliations

  • American Society for Virology
  • American Society for Microbiology
  • Japanese Society for Virology

Research Interests

National Institues of Health, RO1 AI 72493
Principal Investigator
"Analysis of SARS Coronavirus-Host Cell Interactions"
8/5/2007-7/31/2012

National Institutes of Health 1UC1 AI062636-01 (Peters)
Co-PI, (CJ Peters, Principal Investigator)
Rift Valley Fever Virus MP-12 Vaccine Completion
9/15/2004-12/31/2009

Department of Homeland Security
Co-PI, (Clarke at Texas A&M, Principal Investigator, CJ Peters, Subcontract Principal Investigator)
Rift Valley Fever Virus Studies
01/01/2010-12/31/2014

Articles in Peer-Reviewed Journals

  1. Taguchi, F., Yamaguchi, R., Makino, S., and Fujiwara, K. (1981). Correlation between growth potential of mouse hepatitis viruses in macrophages and their virulence for mice. Infect. Immun. 34, 1059-1069.
  2. Taguchi, F., Makino, S., and Fujiwara, K. (1982). Antigenic differentiation of mouse hepatitis viruses by neutralization test. Microbiol. Immunol. 26, 741-745.
  3. Makino, S., Taguchi, F., Fujiwara, K., and Hayami, M. (1982). Heterologous response of antiserum-treated cell clones from a persistently infected DBT cell line to mouse hepatitis virus. Jpn. J. Exp. Med. 52, 297-302.
  4. Makino, S., Taguchi, F., Hayami, M., and Fujiwara, K. (1983). Characterization of small plaque mutants of mouse hepatitis virus, JHM strain. Microbiol. Immunol. 27, 445-454.
  5. Makino, S., Taguchi, F., and Fujiwara, K. (1984). Defective interfering particles of mouse hepatitis virus. Virology 133, 9-17.
  6. Makino, S., Taguchi, F., Hirano, N., and Fujiwara, K. (1984). Analysis of genomic and intracellular RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology 139,138-151.
  7. Makino, S., Fujioka, N., and Fujiwara, K. (1985). Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J. Virol. 54,329-336.
  8. Nakanaga, K., Kitagawa, T., Kiuchi, Y., Makino, S., Hayami, M., and Fujiwara, K. (1985). Production and characterization of monoclonal antibodies to mouse hepatitis virus, MHV-NuU. Jpn. J. Vet. Sci. 47, 423-433.
  9. Lai, M.M.C., Baric, R.S., Makino, S., Keck, J.G. Egbert, J., Leibowitz, J.L.,and Stohlman, S.A. (1985). Recombination between nonsegmented RNA genomes of murine coronaviruses. J. Virol. 56,499-456.
  10. Makino, S., Keck, J.G., Stohlman, S.A., and Lai, M.M.C. (1986). High-frequency RNA recombination of murine coronaviruses. J. Virol 57, 729-737.
  11. Makino, S., Stohlman, S.A., and Lai, M.M.C. (1986). Leader sequences of murine coronavirus mRNAs can be freely reassorted: Evidence for the role of free leader RNA in transcription. Proc. Natl. Acad. Sci. USA. 83, 4204-4208.
  12. Shieh, C.-K., Soe, L.H., Makino, S., Stohlman, S.A., and Lai, M.M.C. (1987). The 5'-end sequence of the murine coronavirus genome: Implications for multiple fusion sites in leader-primed transcription. Virology 156, 321-330.
  13. Keck, J.G., Stohlman, S.A., Soe, L.H., Makino, S., and Lai, M.M.C. (1987). Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology 156, 331-341.
  14. Makino, S., Fleming, J.O., Keck, J.G., Stohlman, S.A., and Lai, M.M.C. (1987). RNA recombination of murine coronaviruses: Localization of neutralizing epitopes and neuropathogenic determinants on the C-terminus of peplomers. Proc. Natl. Acad. Sci. USA. 84, 6567-6571.
  15. Makino, S., Chang, M.-F., Shieh, C.-K., Kamahora, T., Vannier, D.M., Govindarajan, S., and Lai, M.M.C. (1987). Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature (London), 329,343-346.
  16. Makino S., Shieh, C.-K., Keck, J.G., and Lai, M.M.C (1988). Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs. Virology 163,104-111.
  17. Keck, J.G., Matsushima, G.K., Makino, S., Fleming, J.O., Vannier, D.M., Stohlman, S.A., and Lai, M.M.C. (1988). In vivo RNA-RNA recombination of coronavirus in mouse brain. J. Virol. 62, 1810-1813.
  18. Keck, J.G., Soe, L.H., Makino, S., Stohlman, S.A., and Lai, M.M.C. (1988). RNA recombination of murine coronaviruses: Recombination between fusion positive MHV-A59 strain and fusion negative MHV-2 strain. J. Virol. 62, 1989-1998.
  19. Chang M.-F., Baker, S.C., Soe, L.H., Kamahora, T., Keck, J.G., Makino, S., Govindarajan, S., and Lai, M.M.C. (1988). Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J. Virol. 62, 2403-2410.
  20. Makino, S., Soe, L.H., Shieh, C.-K., and Lai, M.M.C. (1988). Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J. Virol. 62, 3870-3873.
  21. Makino, S., Shieh, C.-K., Soe, L.H., Baker, S.C., and Lai, M.M.C. (1988). Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology 166,550-560.
  22. Makino, S., and Lai, M.M.C. (1989). Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology 169, 227-232.
  23. Wu, H.-N., Lin, Y.-J., Lin, F.-P., Makino, S., Chang, M.-F., and Lai, M.M.C. (1989). Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc. Natl. Acad. Sci. USA 86, 1831-1835.
  24. Shieh, C.-K., Lee, H.-J., Yokomori, K., La Monica, N., Makino, S., and Lai, M.M.C. (1989). Identification of a new transcription initiation site and the corresponding functional gene 2b in murine coronavirus RNA genome. J. Virol. 63, 3729-3736.
  25. Yokomori, K., La Monica, N., Makino, S., Shieh, C.-K., and Lai, M.M.C. (1989). Biosynthesis, structure and biological activities of envelope protein gp65 of murine coronavirus. Virology 173, 683-691.
  26. Makino, S., and Lai, M. M. C. (1989). High-frequency leader sequence switching during coronavirus defective-interfering RNA replication. J. Virol. 63, 5285-5292.
  27. Lavi, E., Murray, E. M., Makino, S., Stohlman, S. A., Lai, M. M. C., and Weiss, S. R. (1990).  Determination of coronavirus MHV pathogenesis are localized to 3' portion of the genome as determined by RNA-RNA recombination. Lab. Invest. 62, 570-578
  28. Makino, S., Yokomori, K., and Lai, M. M. C. (1990). Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: Localization of a possible RNA-packaging signal. J. Virol. 64, 6045-6053.
  29. Makino, S., Joo, M., and Makino, J. K. (1991). A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65, 6031-6041.
  30. Jeong, Y. S., and Makino, S. (1992). Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effects of subgenomic RNA transcription on RNA replication. J. Virol. 66, 3339-3346.
  31. Fosmire, J. A., Hwang, K., and Makino, S. (1992). Identification and characterization of a coronavirus packaging signal. J. Virol. 66, 3522-3530.
  32. Joo, M., and Makino, S. (1992). Mutagenic analysis of the coronavirus intergenic consensus sequence. J. Virol. 66, 6330-6337.
  33. Kim, Y.-N., Lai, M. M. C. and Makino, S. (1993). Generation and selection of coronavirus defective interfering RNA with large open reading frame by RNA recombination and possible editing. Virology 194, 244-253.
  34. Makino, S., and Joo, M. (1993). Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J. Virol. 67, 3304-3311.
  35. Kim, Y.-N., Jeong, Y. S., and Makino, S. (1993). Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology 197, 53-63.
  36. Taguchi, F., Ikeda, T., Makino, S., and Yoshikura, H. (1994). A murine coronavirus MHV-S isolated from persistently infected cells has leader and two consensus sequences between the M and N genes. Virology 198, 355-359.
  37. Jeong, Y. S., and Makino, S. (1994). Evidence for coronavirus discontinuous transcription. J. Virol. 68, 2615-2623.
  38. Joo, M., and Makino, S. (1995). The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J. Virol. 69, 272-280.
  39. Kim, K. H., and Makino, S. (1995). Two murine coronavirus genes suffice for viral RNA synthesis. J. Virol. 69, 2313-2321.
  40. Kim, Y.-N., and Makino, S. (1995). Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J. Virol. 69, 4963-4971.
  41. Yokomori, K., Asanaka, M., Stohlman, S. A., Makino, S., Shubin, R. A., Gilmore, W., Weiner, L. P., Wang, F.-I., and Lai, M. M. C. (1995). Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J. NeuroVirol. 1, 330-339.
  42. Jeong, Y. S., Repass, J., Kim, Y.-N., Hwang, S.-M., and Makino, S.  (1996). Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology 217, 311-322.
  43. Joo, M., Banerjee, S., and Makino, S. (1996). Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J. Virol. 70, 5769-5776.
  44. Woo, K., Joo, M., Narayanan, K., Kim, H. K., and Makino, S. (1997). Murine coronavirus packaging signal confers packaging to nonviral RNA. J. Virol. 71, 824-827.
  45. Kim, K. H., Narayanan, K., and Makino, S. (1997). Assembled coronavirus from complementation of two defective interfering RNAs. J. Virol. 71, 3922-3931.
  46. An, S., and Makino, S. (1998). Characterizations of coronavirus cis-acting RNA elements and the transcription step affecting its transcription efficiency. Virology. 243, 198-207.
  47. Repass, J. F., and Makino, S. (1998). Importance of positive-strand RNA secondary structure of an murine coronavirus defective interfering RNA internal replication signal in positive-strand RNA synthesis. J. Virol. 72, 7926-7933.
  48. An, S., Maeda, A., and Makino, S. (1998). Coronavirus transcription early in infection. J. Virol. 72, 8517-8524.
  49. Maeda, A., An, S., and Makino, S. (1998). Importance of coronavirus negative-strand genomic RNA synthesis prior to subgenomic RNA transcription. Virus Research 57, 35-52.
  50. An, S., Chen, C.-J., Yu, X., Leibowitz, J. L., and Makino, S. (1999). Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J. Virol. 73, 7853-7859.
  51. Maeda, J., Maeda, A., and Makino, S. (1999). Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells. Virology 263, 266-272.
  52. Narayanan, K., Maeda, A., Maeda, J., and Makino, S. (2000). Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J. Virol. 74, 8127-8134.
  53. Banerjee, S., An, S., Aimin, Z., Silverman, R. H., and Makino, S. (2000). RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells.  J. Virol. 74, 8793-8802.
  54. Mizutani, T., Repass, J. F., and Makino, S. (2000). Nascent synthesis of leader sequence-containing subgenomic mRNAs in coronavirus genome-length replicative intermediate RNA. Virology 265, 238-243.
  55. Maeda, J., Repass, J. F., Maeda, A., and Makino, S. (2001). Membrane topology of coronavirus E protein. Virology 281, 163-169.
  56. Narayanan, K., and Makino, S. (2001). Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J. Virol. 75, 9095-9067.
  57. Banerjee, S., Repass, J. F., and Makino, S. (2001). Enhanced accumulation of coronavirus defective interfering RNA from expressed negative-strand transcripts by coexpressed positive-strand RNA transcripts. Virology 287, 286-300.
  58. Banerjee, S., Narayanan, K., Mizutani, T., and Makino, S. (2002). Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and viral replication in cultured cells. J. Virol. 76, 5937-5948.
  59. Chen, C.-J., and Makino, S. (2002). Murine coronavirus-induced apoptosis in 17Cl-1 cells involves a mitochondria-mediated apoptotic pathway and its downstream caspase-8 activation and Bid cleavage. Virology 302, 321-332.
  60. Narayanan, K., Chen, C.-J., Maeda, J., and Makino, S. (2003). Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J. Virol. 77, 2922-2927.
  61. Narayanan, K., Kim, K.H., and Makino, S. (2003). Characterization of N protein self-association in coronavirus ribonucleoprotein complexes. Virus Research 98, 131-140.
  62. Chen, C.-J., and Makino, S. (2004). Murine coronavirus replication induces cell cycle arrest in G0/G1 phase. J. Virol. 78, 5658-5669.
  63. Chen, C-J., Sugiyama, K., Kubo, H., Huang, C., and Makino, S.  (2004). Murine coronavirus nonstructural protein p28 arrests cell cycle in G0/G1 phase. J. Virol. 78, 10410-10419.
  64. Ito, N., Mossel, E.C., Narayanan, K., Popov, V. L., Huang, C., Inoue, T., Peters, C. J., and Makino, S. (2005). Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J. Virol. 79, 3182-3186.
  65. Mossel, E. C., Huang, C., Narayanan, K., Makino, S., Tesh, R.B., and Peters, C. J. (2005). Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication. J. Virol. 79, 3846-3850.
  66. Ikegami, T., Peters, C.J., and Makino, S. (2005). Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. . J. Virol. 79, 5606-5615.
  67. Tseng, C.-T. K., Perrone, L., Zhu, H., Makino, S. and Peters, C. J. (2005). SARS and the innate immune responses: modulation of effector cell function without productive infection. J. Immunol. 174, 7977-7985.
  68. Ikegami, T., Won, S., Peters, C.J., and Makino, S. (2005). Rift Valley fever virus NSs messenger RNA is transcribed from incoming antiviral-sense S segment. J. Virol. 79, 12106-12111.
  69. Huang, C., Narayanan, K., Ito, N., Peters, C.J., and Makino, S.  (2006). Severe acute respiratory syndrome coronavirus 3a protein is released in membranous structures from 3a protein-expressing cells and infected cells. J. Virol. 80, 210-217.
  70. Ikegami, T., Won, S., Peters, C.J., and Makino, S.  (2006). Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking NSs gene, and expression of a foreign gene. J. Virol. 80, 2933-2940.
  71. Huang, C., Ito, N., Tseng, C.-T.K., and Makino, S.  (2006). Severe acute respiratory syndrome coronavirus 7a accessory protein is a viral structural protein. J. Virol. 80, 7287-7294.
  72. Won, S., Ikegami, T., Peters, C.J., and Makino, S.  (2006). NSm and 78-kilodalton proteins of Rift Valley Fever virus are nonessential for viral replication in cell culture. J. Virol. 80, 8274-8278.
  73. Kamitani, W., Narayanan, K., Huang, C., Lokugamage, K., Ikegami, T., Ito, N., Kubo, H., and Makino, S.  (2006). Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc. Natl. Acad. Sci. USA, 103, 12885-12890.
  74. Tseng, C.-T.K., Huang, C., Newman, P., Wang, N., Narayanan, K., Watts, D.M., Makino, S., Packard, M., Zaki, S., Chan, T-S., and Peters, C.J. (2007). Severe acute respiratory syndrome coronavirus infection of mice transgenic for human angiotensin-converting enzyme 2 virus receptor. J. Virol. 81, 1162-1173.
  75. Huang, C., Peters, C.J., and Makino, S. (2007).   Severe acute respiratory syndrome coronavirus accessory protein 6 is a virion-associated protein and is released from 6 protein-expressing cells. J. Virol. 81, 5423-5426.
  76. Ikegami, T., Won, S., Peters, C.J., and Makino, S. (2007). Characterization of Rift Valley fever virus transcription terminations. J. Virol. 81, 8421-8438.
  77. Won, S., Ikegami, T., Peters, C.J., and Makino, S. (2007).  NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J. Virol. 81, 13335-13345.
  78. Narayanan, K., Huang, C., and Makino, S. (2008). SARS coronavirus accessory proteins. Virus Research, 133, 113-121.
  79. Lokugamage, K., Yoshikawa-Iwata, N., Ito, N., Watts, D.M., Wyde, P.R., Wang, N., Newman, P., Tseng, C.-T.K., Peters, C.J., and Makino, S. (2008). Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protects mice against challenge with SCoV. Vaccine, 26, 797-808.
  80. Narayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.-T. K., and Makino, S.  (2008). Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 82, 4471-4479. (This paper is one of five spotlight articles, which are selected from this issue by the editors.).
  81. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J., and Makino, S. (2009). Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2a phosphorylation. PLoS Pathogens, 5(2), e10000287.
  82. Tohya, Y., Narayanan, K., Kamitani, W., Huang, C., Lokugamage, K., and Makino, S. (2009). Suppression of host gene expression by nsp1 proteins of group 2 bat coronaviruses. J. Virol. 83, 5282-5288.
  83. Yoshikawa, N., Yoshikawa, T., Hill, T., Huang, C., Watts, D. M., Makino, S., Milligan, G., Chan, T., Peters, C. J., and Tseng, C.-T. K. (2009). Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2. J. Virol. 83, 5451-5465.
  84. Ikegami, T., and Makino, S. (2009). Rift Valley fever virus vaccines. Vaccine, 27, D69-D72.
  85. Kamitani, W., Huang, C., Narayanan, K., Lokugamage, K., and Makino, S. (2009). A novel two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein. Nature Struct. Mol. Biol. 16, 1134-1140.
  86. Zamoto-Niikura, A., Terasaki, K., Ikegami, T., Peters, C. J., and Makino, S. (2009). Rift Valley fever virus L protein forms a biologically active oligomer. J. Virol. 83, 12779-12789.
  87. Morrill, J. C., Ikegami, T., Yoshikawa-Iwata, N., Lokugamage, N., Won, S., Terasaki, K., Zamoto-Niikura, A., Peters, C. J., and Makino, S. (2010). Rapid accumulation of virulent Rift Valley fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the M RNA. PLoS ONE, 5(4) e9986.

REVIEWS and BOOK CHAPTERS

  1. Hirano, N., Goto, N., Makino, S., and Fujiwara, K (1981). Persistent infection with mouse hepatitis virus JHM strain in DBT cell culture. In Advances in Experimental Medicine and Biology, Vol. 142, pp. 301-308. Plenum, New York.
  2. Lai, M.M.C., Makino, S., Baric, R.S., Soe, L., Shieh, C.-K., Keck, J.G. and Stohlman, S.A. (1987). Leader RNA-primed transcription and RNA recombination of murine coronaviruses. In Positive Strand RNA Viruses, pp.285-297. Alan R.Liss, Inc., New York.
  3. Makino, S., Chang, M.-F., Shieh, C.-K., Kamahora, T., Vannier, D.M., Govindarajan, S., and Lai, M.M.C. (1987). Molecular biology of a human hepatitis delta virus RNA. In Hepadna viruses, pp.549-564. Alan R. Liss, Inc., New York.
  4. Makino, S., Fujiwara, K., and Lai, M.M.C. (1987). Defective-interfering particles of mouse hepatitis virus. In Advances in Experimental Medicine and Biology, Vol. 218, pp. 187-195. Plenum, New York.
  5. Keck, J.G., Makino, S., Soe, L.H., Fleming, J.O., Stohlman, S.A. and Lai, M.M.C. (1987). RNA recombination of coronaviruses. In Advances in Experimental Medicine and Biology. Vol. 218, pp.99-107. Plenum, New York.
  6. Soe, L.H., Shieh, C.-K., Makino, S., Chang, M.-F., Stohlman, S.A., and Lai, M.M.C. (1987). Murine coronavirus 5'-end genomic RNA sequence reveals mechanism of leader primed-transcription. In Advances in Experimental Medicine and Biology, Vol. 218, pp.78-81. Plenum, New York.
  7. Goto, N., Makino, S., and Fujiwara, K. (1987). Neuropathogenicity of mutant strains of mouse hepatitis virus 1a and 2c, from DBT cells persistently infected with JHM strain. In Advances in Experimental Medicine and Biology, Vol.218, pp.439-440. Plenum, New York. 
  8. Lai, M.M.C., Makino, S., Soe, L.H., Shieh, C.-K., Keck, J.G., and Fleming, J.O. (1987). Coronavirus: A jumping RNA transcription. In "The evolution of catalytic function, Vol. LII, pp.359-365. Cold Spring Harbor symposium on quantitative biology, Cold Spring Harbor, New York.
  9. Govindarajan, S., Makino, S., Gupta, B., and Lai, M.M.C. (1987). Molecular studies of hepatitis delta virus RNA in human and chimpanzee serum and liver tissues. Study of acute and chromic delta hepatitis. In Viral Hepatitis and Liver Diseases, (ed. A.J. Zuckerman) pp. 400-402. Alan Liss Inc., New York.
  10. Makino, S., and Lai, M. M. C. (1990) Studies of coronavirus DI RNA replication using in vitro constructed DI cDNA clones. In Advances in Experimental Medicine and Biology, Vol. 276, pp.341-347. Plenum, New York.
  11. Makino, S. (1991). Studies of coronavirus genomic RNA packaging. In Experimental Medicine, Yodosha (in Japanese) Vol. 9, pp. 345-347.
  12. Joo, M., and Makino, S.  (1993). Analysis of the cis-acting elements of coronavirus transcription. In Advances in Experimental Medicine and Biology, Vol. 342, pp. 91-98. Plenum, New York.
  13. Kim, Y.-N., Lai, M. M. C., and Makino, S.  (1993). Site-specific sequence repair of coronavirus defective interfering RNA by RNA recombination and edited RNA. In Advances in Experimental Medicine and Biology, Vol. 342, pp.137-142. Plenum, New York .
  14. Schlesinger, S., Makino, S., and Linial, M. L. (1994). cis-Acting genomic elements and trans-acting proteins involved in the assembly of RNA viruses. Sem. Virol. 5, 39-49.
  15. Joo, M., and Makino, S.  (1995). Analysis of the coronavirus transcription regulation. In Advances in Experimental Medicine and Biology, Vol. 380, pp. 473-478. Plenum, New York.
  16. Kim, K. H., and Makino, S.  (1995). Expression of murine coronavirus genes 1 and 7 is sufficient for viral RNA synthesis. In Advances in Experimental Medicine and Biology, Vol. 380, pp. 479-484. Plenum, New York.
  17. Kim, K. H., Narayanan, K., and Makino, S. (1998). Characterization of coronavirus DI RNA packaging. In Advances in Experimental Medicine and Biology, Vol.440, pp. 347-353. Plenum, New York
  18. Banerjee, S., and Makino, S. (1998). Studies of murine coronavirus DI RNA replication from negative-strand transcripts. In Advances in Experimental Medicine and Biology, Vol.440, pp. 241-246. Plenum, New York.
  19. Repass, J. F., and Makino, S. (1998). The effect of deletion of a conserved 11 nucleotide sequence on mouse hepatitis virus RNA replication. In Advances in Experimental Medicine and Biology, Vol.440, pp. 247-252.  Plenum, New York
  20. Makino, S. (2000). Analysis of transcriptional control in RNA virus infection. In RNA viruses: A Practical Approach. (ed. Cann, A. J.). pp. 43-67. Oxford University press, Oxford, New York, Tokyo.
  21. Chen, C.-J., An, S., and Makino, S. (2001). Induction of apoptosis in murine coronavirus-infected 17Cl-1 cells. In Advances in Experimental Medicine and Biology, Vol. 494, pp. 615-620. Plenum, New York.
  22. Banerjee, S., An, S., and Makino, S. (2001). Specific cleavage of 28S ribosomal RNA in murine coronavirus-infected cells. In Advances in Experimental Medicine and Biology, Vol. 494, pp. 621-626. Plenum, New York.
  23. Narayanan, K., and Makino, S. (2001). Characterization of nucleocapsid-M protein interaction in murine coronavirus. In Advances in Experimental Medicine and Biology, Vol. 494, pp. 577-582. Plenum, New York.
  24. Ikegami, T., and Makino, S. (2004). Rift Valley fever virus. In Virus, 54, 229-236, (in Japanese) The Japanese Society for Virology, Tokyo, Japan.
  25. Narayanan, K., and Makino, S (2007).Coronavirus genome packaging. In Coronaviruses: Molecular Biology and Diseases (ed. Thiel, V.). pp. 131-142.  Horizon Scientific Press, Norwick, UK.
  26. Narayanan, K., Huang, C., and Makino, S. (2008). Coronavirus accessory proteins. In The Nidoviruses (eds. Perlman, S., Gallagher, T., and Snijder, E.) pp 235-244. ASM Press.
  27. Narayanan, K., and Makino, S (2008).Coronaviruses and Arteriviruses.  InCellular Signaling and Innate Immune Responses to RNA Virus infections (eds. Brasier, A., Garcis-Sastre, A., and Lemon, S.M.) pp373-387. ASM Press.
  28. Ikegami, T., and Makino, S. (2009). Rift Valley fever virus (in Japanese). In Zoonosis Handbook, pp. 77-79. Medical Press, Tokyo, Japan.
  29. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J., and Makino, S. (2009). Dual functions of Rift Valley fever virus NSs protein: Inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. In Immunology and Pathogenesis of Viral Hemorrhagic Fevers: Annals of the New York Academy of Sciences, vol. 1171, E75-E85.